Flavia Borellini's most recent trade in Pliant Therapeutics Inc was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pliant Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 3,127 | 3,127 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 1,191 | 26,215 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 11,574 | 11,574 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 3,142 | 25,024 (0%) | 0% | 0 | Common Stock | |
| Viracta Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,955 | 15,955 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 22,434 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,248 | 21,882 (0%) | 0% | 0 | Common Stock | |
| Viracta Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,200 | 17,634 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 5,200 | 12,434 (0%) | 0% | 0 | Common Stock | |
| Viracta Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Viracta Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) |